Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes
Yahoo/Zacks.com
Tuesday, September 23, 2014 - 7:46am
tags:
Novo Nordisk, Xultophy, diabetes, Tresiba, Victoza
Will Allergan Acquire Salix, Or Be Acquired Itself?
Bidness Etc.
Tuesday, September 23, 2014 - 7:45am
tags:
Allergan, Salix, Valeant Pharmaceuticals, Actavis, M&A
Boehringer aims to cut up to 600 jobs in Germany
Yahoo/Reuters
Tuesday, September 23, 2014 - 7:38am
tags:
Boehringer Ingelheim, layoffs, Germany
Inversion Deal Crackdown Sends AstraZeneca, Shire Down
Bloomberg
Tuesday, September 23, 2014 - 7:37am
tags:
AstraZeneca, Shire, tax inversions
Amgen One Step Closer To Immunotherapy Market
Bidness Etc.
Tuesday, September 23, 2014 - 7:33am
tags:
Amgen, immunotherapy, blinatumomab, acute lymphoblastic leukemia
Botox maker Allergan rejected Actavis takeover bid
Morningstar
Monday, September 22, 2014 - 10:17pm
tags:
Allergan, Actavis, M&A
Did Someone say Kickbacks? HHS Warns About Medicare Part D Coupons
WSJ Pharmalot
Monday, September 22, 2014 - 10:12pm
tags:
HHS, Medicare Part D, Medicare, kickbacks
U.S. court orders Allergan to produce board documents
Yahoo/Reuters
Monday, September 22, 2014 - 10:09pm
tags:
Allergan, Valeant Pharmaceuticals, M&A, Pershing Square
Allergan revives talks to acquire Salix -source
Reuters
Monday, September 22, 2014 - 8:43pm
tags:
Allergan, Salix, M&A
Key Pharma Events For the Week Ahead
Bidness Etc.
Monday, September 22, 2014 - 3:47pm
tags:
Celgene, Otezla, CHMP, Gilead Sciences, Roche, Novartis, Merck, Eli Lilly, JNJ, GSK, Sanofi, Teva
Roche launches US$5.75bn bond to back InterMune deal -lead
Yahoo/Reuters
Monday, September 22, 2014 - 3:43pm
tags:
Roche, InterMune, M&A
Gilead Sciences: A Preview of Important HIV Drug Study Results
TheStreet.com
Monday, September 22, 2014 - 2:48pm
tags:
Gilead Sciences, HIV, tenofovir
3 Partnerships Pushing The Pharmaceutical Sector Forward
Yahoo/Benzinga
Monday, September 22, 2014 - 2:46pm
tags:
AbbVie, Infinity Pharmaceuticals, Clevexel Pharma, Guilin Pharmaceutical, The Chiesi Group, Pappas & Associates
3 Stocks Pulling The Drugs Industry Downward
TheStreet.com
Monday, September 22, 2014 - 2:42pm
tags:
AbbVie, Pfizer, Gilead Sciences
GlaxoSmithKline, Avalon launch a pair of new build-to-buy biotechs
Fierce Biotech
Monday, September 22, 2014 - 12:50pm
tags:
GSK, biotech, Avalon Ventures, Silarus Therapeutics, Thyritope Biosciences
An Eisai Special? Bill Would Speed DEA Listings for Controlled Substances
WSJ Pharmalot
Monday, September 22, 2014 - 12:09pm
tags:
Eisai, DEA, controlled substances
FDA authorizes emergency use of Tekmira's Ebola treatment
Reuters
Monday, September 22, 2014 - 10:09am
tags:
Tekmira Pharmaceuticals, ebola virus, FDA
TauRx hits milestone in mild Alzheimer's trial
Pharmaphorum
Monday, September 22, 2014 - 10:00am
tags:
TauRx, Alzheimer's disease, LMTX
J&J Likely To Report Drop In Zytiga Sales On Xtandi‘s Entry In Prostate Cancer Market
Bidness Etc.
Monday, September 22, 2014 - 9:56am
tags:
Zytiga, Xtandi, JNJ, prostate cancer, Medivation, Astellas
Did Boston Scientific lose $74M mesh trial over an email?
Mass Device
Monday, September 22, 2014 - 9:54am
tags:
Boston Scientific, devices, pelvic mesh

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.